Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy
Background: Breast cancer incidence rate in Belgian women was as high as 152.7 for 100 000 in 2003 (adjusted on European population). We made an estimation of the contribution of hormone replacement therapy (HRT) on breast cancer incidence from 1999 to 2005 in women aged 50–69 years in Flanders. Methods: Breast cancer data were extracted from the Belgium Cancer Registry. Drug consumption was computed from drug sales data. The fraction of breast cancers attributable to HRT was calculated by year, using the relative risks of the Million Women Study in the UK. Results: The proportion of women age... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | TEXT |
Erscheinungsdatum: | 2010 |
Verlag/Hrsg.: |
Oxford University Press
|
Schlagwörter: | original article |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26614096 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://annonc.oxfordjournals.org/cgi/content/short/mdq240v1 |